CPO
CORT icon

Cerity Partners OCIO’s Corcept Therapeutics CORT Stock Holding History

Cerity Partners OCIO’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,357
Closed -$585K – 382
2020
Q4 		$585K Buy
+22,357
New +$471K 0.02% 240

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cerity Partners OCIO's CORT Position: Q1 2021 in Review

Cerity Partners OCIO sold out of Corcept Therapeutics (CORT) in Q1 2021, closing a stake of 22,357 shares — an estimated $585K sold.

Cerity Partners OCIO first reported a position in CORT in Q4 2020 and held it in 1 quarter. The position peaked at $585K in Q4 2020. 209 funds tracked by Wall St. Rank hold CORT as of Q1 2021.

  • Cerity Partners OCIO reported no remaining Corcept Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Cerity Partners OCIO sold 22,357 Corcept Therapeutics shares in Q1 2021, an estimated $585K.
  • Cerity Partners OCIO first reported a position in Corcept Therapeutics in Q4 2020 and held it in 1 quarter.
  • Cerity Partners OCIO's Corcept Therapeutics position peaked at $585K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2021.

Based on Cerity Partners OCIO's 13F filing for Q1 2021, filed 6 May 2021.